Jayex Technology Limited (AU:JTL) has released an update.
Jayex Technology Limited, a UK-based SaaS healthcare services provider, has reported a decrease in quarterly cash receipts to $0.95 million and an operational cash outflow increase to $588k for the first quarter of 2024. Despite initial working capital constraints, the company has shown month-on-month growth in installations and hardware revenue following a $500k bank loan. Additionally, the appointment of a new Commercial Director and progress in the Symbia Health joint venture suggests potential for future expansion.
For further insights into AU:JTL stock, check out TipRanks’ Stock Analysis page.
